Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
166 Cards in this Set
- Front
- Back
First fat soluble vitamin discovered?
|
Vitamin A
|
|
Where are fat soluble vitamins stored?
|
Liver
|
|
Hormone-like vitamin?
|
Vitamin A
|
|
Fat soluble vitamins?
|
A,D,E & K
|
|
Vitamin A is synthesized in the body. True or false?
|
False
|
|
List the 4 forms of Vitamin A.
|
Retinol
Retinal Retinoid Retinyl esters |
|
Form of Vitamin A stored and transported in the body?
|
Retinol
|
|
Form of Vitamin A required for vision?
|
Retinal
|
|
Biologically active form of Vitamin A Responsible for mediating the effects of vitamin A in the body?
|
Retinoic acid
|
|
Form of Vitamin A ingested as food or supplement?
|
Retinyl esters
|
|
List the pro-Vitamin A carotenoids converted to Vitamin A by the body?
|
α-carotene
β-carotene γ-carotene Cryptoxanthin |
|
Pro-Vitamin A carotenoid best converted to Vitamin A and absorbed by the body?
|
β-carotene
|
|
Name 3 sources of retinyl esters from animals?
|
Palmitic acid
Myristic acid Dodecanoic acid |
|
Vitamin that stimulates epitheleal mucous production?
|
Vitamin A
|
|
Short-term dermatological effect of Hypervitaminosis A?
|
Desquamation
|
|
Short-term ophthalmic effects of Hypervitaminosis A?
|
Papilledema
Scotoma Blind spots Photophobia |
|
Teratogenic Effects of Retinoid drugs?
|
Craniofacial
Neural tube Urogenital Musculoskeletal |
|
How do carotenoids enter the enterocytes from the GI lumen?
|
Passive diffusion
|
|
Where are carotenoids transformed into usable retinol?
|
In the enterocytes
|
|
Where are retinyl esters transformed to retinol?
|
In the GI lumen
|
|
What type of enzyme transforms retinyl esters to retinol in the GI lumen?
|
Hydrolases
|
|
How does retinol in the GI lumen enter the enterocytes?
|
Through facilitated diffusion
|
|
What happens to retinol once it enters the enterocytes?
|
Retinol is esterfied and transferred to the liver for storage
|
|
Name the intercellular proteins that function in the transport of retinol.
|
Cellular Retinoic Binding Proteins (CRBPs)
|
|
What are the 4 functions of Cellular Retinoic Binding Proteins (CRBPs)?
|
Transport retinol. Present retinols to appropriate enzymes for esterification.
Protect retinols from enzymes and environment. Control concentrations of free retinol in cell. |
|
In what for are retinols stored in the body?
|
As esters
|
|
Where does esterfication of retinol occur?
|
In the enterocytes
|
|
Which enzyme esterfies retinol after presentation by CRBPs?
|
LRAT – Lecithin-retinol acyltransferase
|
|
Which enzyme is upregulated in the enterocytes when retinol levels reach excessive levels?
|
ARAT – Acylcoenzyme A retinol acyltransferase
|
|
What lipoproteins transport retinol to the liver?
|
Chylomicrons
|
|
How to chylomicrons move from the small intestine to the liver?
|
They leave the small intestine through the lymphatic system and enter circulation at subclavian vein.
|
|
Retinyl esters are hydrolyzed to retinol in hepatocytes and then bound to RBPs (retinol binding proteins). Where are the retinol binding proteins found?
|
In the endoplasmic reticulum (ER) of hepatocytes.
|
|
Which liver cells actually store the Retinol-RBP complexs?
|
Liver stellate cells
|
|
What happens to retinol in the liver stellate cells if the body does not require its immediate use?
|
Retinol is bound to CRBP and re-esterified for storage by ARAT or LRAT.
|
|
What happens when the body requires stored retinol?
|
Retinyl esters are hydrolyzed.
Retinol is released into circulation. Retinol is transported in a complex with RBP |
|
What happens when the Retinol-RBP complex travels to cell surface?
|
The complex interacts with transthyretin (TTR), a plasma protein that helps mediate retinol transfer to cell surface receptors for transport into the cell.
|
|
What else does TTR bind?
|
Thyroxine
|
|
Which protein transfers retinol from systemic circulation into the cell?
|
Transthyretin (TTR)
|
|
RBP and TTR enter the cell along with retinol. True or false?
|
False
|
|
What happens to the retinol once it enters the cell where it will be used?
|
Retinol binds again to CRBP, which delivers it to appropriate site for conversion to active form
|
|
What is the rate limiting step in the conversion of retinol -> retinal -> retinoic acid?
|
RoDH: Retinol dehydrogenase
|
|
Name the protein that serves as retinal’s body guard in the cytoplasm of the cell?
|
CRABP: Cellular Retinoic Acid Binding Protein
|
|
Where does retinoic acid mediate its action?
|
In the cell nucleus
|
|
How does retinoic acid mediate its action?
|
By binding to nucleur receptors and acting as a transcription regulator
|
|
Name the two distinct forms of retinoic acid that are biologically active?
|
All-trans-retinoic acid
9-cis-retinoic acid |
|
What does all-trans-retinoic acid bind to in the cell nucleus?
|
RA binds to RARs (Retinoic Acid Receptors), a, b, and g
|
|
What does 9-cis-retinoic acid bind to in the cellular nucleus?
|
9-cis-RA binds to RXRs (Retinoic Acid X Receptors), alpha, beta and gamma
|
|
RARs and RXRs can homo-dimerize with their own kind, but can the hetero-dimerize with each other?
|
Yes, RARs and RXRs can homo and hetero-dimerize.
|
|
Where to the dimers bind to regulate gene transciption?
|
They bind to DNA response elements
|
|
Which retinoic acid receptors are predominant in the skin?
|
RAR alpha and beta
|
|
How is retinol metabolized in the body?
|
Through glucuronidation and enterohepatic cycling. Unchanged retinol is normally not excreted.
|
|
How is retinoic acid metabolized in the body?
|
Through decarboxylation and glucoronide formation and excretion in the urine and feces. There is no specific carrier in the blood for retinoic acid.
|
|
With respect to medicinal chemistry, which part of the retinoid structure is absolutely required for receptor activity?
|
The cyclical β-ionone ring.
|
|
All-trans-retinol?
|
Retinol
|
|
All-trans retinoic acid?
|
Tretinoin (Retin-A)
|
|
13-cis-retinoic acid?
|
Isotretinoin (Accutane) 1st generation retinoid
|
|
9-cis-retinoic acid?
|
Alitretinoin (Panretin) 1st generation retinoid
|
|
Second Generation Retinoids – Aromatic Retinoids?
|
Etretinate (Tegison)
Acitretin (Soriatane) (Etretinate removed due to birth defects) |
|
Third Generation Retinoids - Arotinoids
|
Tazarotene (Tazorac)
Bexarotene (Targretin) Adapalene (Differin) |
|
Which class of retinoids is most specific for retinoic acid receptors?
|
The third generation.
|
|
Why are third generation retinoids more specific for retinoid acid receptors?
|
Reduced flexibility of the side chain.
|
|
What is the trade name for Tazarotene?
|
Tazorac
|
|
What is the trade name for Bexarotene?
|
Targretin
|
|
What is the trade name for Adapalene?
|
Differin
|
|
Glands that produce most sweat and are concentrated in the palms, forehead and soles of feet?
|
Ecrine glands
|
|
Odorous glands of the axillary and anogenital areas?
|
Apocrine glands
|
|
Ceruminous glands and mammary glandsare frequently considered to be modified sweat glands. What category to these glands belong to?
|
Ecrine
|
|
Enlarged and plugged hair follicles?
|
Comedos
|
|
Glands that secrete sebum to lubricate skin and hair, slow water loss and act as bactericidal agents?
|
Alveolar glands
|
|
Accumulation of sebum that blocks sebaceous gland ducts and causes inflammation?
|
Acne
|
|
Mechanism of action of Retin-A (all-trans retinoic acid)?
|
Reduces the hyperkeratinization that leads to comedone formation.
Decreases adhesion of corneocytes. Increases shedding and prevents blockage of gland openings. |
|
Systemic retinoids?
|
Accutane (Isotretinoin)
Soriatane (Acitretin) |
|
Some retinoids remain teratogenic even after discontinued use. Explain this prolonged teratogenic effect?
|
Acitretin and Ecetretin sequester in fat cells
|
|
Topical retinoids?
|
Retin-A
Tazorac (Tazarotene) Differin (Adapalene) |
|
Topical retinoid prodrug selective for RAR-b and RAR-gamma?
|
Tazorac (Tazarotene)
|
|
Topical retinoid that binds with RARs but will not bind RXRs or CRABPs?
|
Differin (Adapalene)
|
|
Topical retinoid with anti-inflammatory effects?
|
Differin (Adapalene)
|
|
Non-Retinoid Keratolytics?
|
Salycylic acid
Benzoyl peroxide Propylene glycol |
|
Non-retinoid keratolytic that is converted to lactic acid and pyruvic acid, removes hyperkeratotic debris and increases water content of stratum corneum?
|
Propylene glycol
|
|
Significance of the 4,5 double bond and 3-keto group on ring A of steroid drugs?
|
Glucocorticoid and mineralocorticoid activity
|
|
Significance of 11β-hydroxyl group on ring C of steroid drugs?
|
Glucocorticoid activity
|
|
Significance of the 17α-hydroxyl group on ring D of steroid drugs?
|
Optimal potency
|
|
Addition of double bond on 1,2 position of ring A of steroid drugs?
|
Increases glucocorticoid activity and slows metabolism
|
|
Fluorination at 9α on ring B of steroid drugs?
|
Enhanced activity
|
|
C16 subsitutions on ring D of steroid drugs?
|
Elimination of mineralocorticoid activity
|
|
Adverse effects spcifically related to fluorinated steroid drugs?
|
Perioral dermatitis and Rosacea
|
|
Augmented betamethasone dipropionate (Diprolene) ?
|
Very high potency steroid
|
|
Fluocinonide(Lidex, Lidex-E) 0.05%
|
High potency steroid
|
|
Mometasone furoate (Elocon) 1.0%
|
Medium potency steroid
|
|
Which potency of steroids causes skin blanching the fastest under the Vasoconstrictor Assay
|
High potency
|
|
Clobetasol propionate (Cormax, Embeline, Embeline E, Temovate, Olux, Clobex, Clobevate)?
|
Very high potency steroid
|
|
What keeps glucocorticosteroid receptors inactive inside the cell?
|
Heat check (IP) proteins
|
|
Steroid receptors enter the cell nucleus and dimerize when activated, where the bind _________?
|
DNA response elements (GREs)
|
|
Diflorasone diacetate (ApexiCon E cream, Florone cream, Psorcon E) 0.05%
|
High potency steroid
|
|
Fluticasone propionate (Cutivate) 0.05%
|
Medium potency steroid
|
|
Betamethasone valerate 0.1%
|
High potency steroid
|
|
Diflorasone diacetate (ApexiCon) 0.05%
|
Very high potency steroid
|
|
Fluocinonide (Vanos) 0.1%
|
Very high potency steroid 0.1%
|
|
Halcinonide (Halog)
|
High potency steroid
|
|
Amevive?
|
Alefacept (T-Cell modulator)
|
|
Raptiva
|
Efalizumab (T-Cell modulator)
|
|
Enbrel
|
Etanercept (T-Cell modulator)
|
|
Infliximab
|
Remicade (T-Cell modulator)
|
|
Dimeric fusion protein combination of human LFA-3 and human IgG1 that binds CD2 to induce apoptosis of memory-effector T cells and inhibit cutaneous T-cell activation and proliferation?
|
Alefacept (Amevive)
|
|
T-cell modulator that requires weekly IM injections?
|
Alefacept (Amevive)
|
|
Monoclonal antibody (IgG1) against CD11-α integrin subunits of LFA-1 on T-cell surface molecule involved in T-cell activation? Inhibits T-cell migration into skin and cytotoxic T-cell function?
|
Efalizumab (Raptiva)
|
|
Antibody portion that determines type of Ig?
|
FC
|
|
T-Cell modulator requiring weekly SC injection?
|
Efalizumab (Raptiva)
|
|
Genetically engineered fusion protein that combines TNF-α receptor with human IgG1? Binds Tumor Necrosis Factor α (TNF-α) and prevents TNF- α from binding to its receptor? Administered SC.
|
Etanercept (Enbrel)
|
|
Chimeric monoclonal antibody (IgG1) that binds free and membrane bound TNF- α and prevents binding of TNF- α to its receptor? Requires IV infusion.
|
Infliximab (Remicade)
|
|
Most common class of drugs that cause drug induced skin reactions?
|
Antibiotics (mostly -cillins)
|
|
Immunologic skin reactions frequently caused by penicillin (PCN) and other related drugs that occurs in minutes to days due to the mast cell release of chemical mediators that cause edema and vasodilation?
|
IgE-dependent reactions
|
|
Immunologic skin reactions commonly caused by PCNs, sulfonamides, phenytoin and aminosalicylic acid. Symptoms typically appear six + days after exposure and are due to antigen-antibody complexes?
|
Serum sickness
|
|
Nonimmunologic skin reactions?
|
Activation of effector pathways
Phototoxicity Exacerbation of existing disease Inherited enzyme or protein deficiencies Alterations of immunologic status |
|
Key factor in the diagnosis IgE mediated skin reactions?
|
Onset of minutes to days after exposure
|
|
Drug induced skin reaction characterized by fever and arthritis?
|
Serum sickness
|
|
Pruritic, red wheals that rarely last more than 24 hours?
|
Urticaria
|
|
Urticaria with swollen dermal and subcutaneous tissues?
|
Angioedema
|
|
Drug mechanism of action that causes urticaria and/or angioedema?
|
IgE-dependent reactions, serum sickness, or activation of effector pathways
|
|
Common drug causes of urticaria and/or angioedema?
|
Non-steroidal anti-inflammatory drugs (NSAIDs), angiotensin-converting enzyme (ACE) inhibitors, radiographic dyes
|
|
Common drug causes of photosensitivity eruptions?
|
fluoroquinolones and doxycycline
|
|
Common drug causes of pigmentation changes?
|
Oral contraceptives → melasma
Long-term minocycline → blue/grey pigmentation Amiodarone → purple pigmentation Long-term high-dose phenothiazine → grey-brown pigmentation (sun exposed areas) Chemotherapeutic agents |
|
Purpuric lesions that develop 7- 10 days after initiation of drug; usually caused by propylthiouracil, allopurinol, thiazides, sulfonamides, PCN, and some NSAID.
|
Vasculitis
|
|
Mechanism causing vasculitis
|
Serum sickness
|
|
Erythematous eruption that may become purpuric and/or lichenoid that is often accompanied by fever, facial edema, and hepatitis and usually begins 2-8 weeks after drug administration.
|
Hypersensitivity syndrome
|
|
Mechansim causing hypersensitivity syndrome?
|
Idiosyncratic, genetic inability to detoxify toxic metabolic products
|
|
Most common drug(s) associated with hypersensitivity syndrome?
|
Phenytoin. Others include lamotrigine, minocycline, dapsone, allopurinol, sulfonamides, abacavir, and zalcitabine
|
|
Sharply demarcated, erythematous lesions that are indurated and purpuric and may progress to hemorrhagic bullae? Mostly seen in women 3-10 days into treatment
|
Warfarin necrosis of the skin
|
|
Mechanism explaining Warfarin Necrosis of Skin?
|
Warfarin causing a decrease in protein C that leads to hypercoagulability which causes necrosis
|
|
Other causes of drug induced necrosis of the skin?
|
Heparin, probably due to heparin-induced platelet aggregation occluding blood vessels
|
|
Skin rash marked by symmetric erythematous macules that often start on the trunk and eventually become confluent? These eruptions are classified as early (few hours to 3 days after administration) or late (≤ 9 days after exposure.
|
Morbilliform Reactions
|
|
Mechanism explaining drug induced morbilliform reactions?
|
Unknown
|
|
Drugs known to cause morbilliform reactions?
|
PCNs and sulfonamides.
1% of patients using PCN have cutaneous reaction; 85% of those are morbilliform |
|
Skin reaction marked by one or more sharply demarcated erythematous lesions with acute inflammation followed by hyperpigmentation? Lesion recurs in the same location upon re-challenge.
|
Fixed drug eruptions
|
|
Mechanism explaining fixed drug eruptions?
|
Mechanism unknown, although genetic susceptibility may play a role
|
|
Drugs known the cause activation of effector pathways leading to nonimmunlogical skin reactions?
|
Opiates, polymixin-B and radio contrast media
|
|
Drugs that commonly cause fixed drug eruptions?
|
Sulfonamides, tetracyclines, phenylbutazone, NSAIDs, and barbiturates
|
|
Skin reactions marked by small groupings of shiny, polygonal papules known as Wickham’s Striae?
|
Lichenoid Drug Eruptions
|
|
Mechanism explaining lichenoid drug eruptions?
|
Thought to be immunologic
|
|
Common drug causes of lichenoid drug eruptions?
|
Gold salts and antimalarials
|
|
Skin rash marked by small pustules overlying erythematous skin that coalesce and lead to ulceration? This reaction presents with fever lesions that appear 1-3 weeks after drug exposure.
|
Acute generalized exanthematous pustulosis (AGEP)
|
|
Mechanisim explaining Acute generalized exanthematous pustulosis (AGEP)?
|
Mechanism unknown
|
|
Common drug causes of acute generalized exanthematous pustulosis (AGEP)?
|
Antibiotics, lithium, glucocorticoids, and phenytoin
|
|
Skin reaction characterized by “butterfly” rash on cheeks and nose with photosensitivity and slightly raised erythemous rash? Systemic symptoms present most of the time and 90% of cases occur in women of childbearing years.
|
Systemic Lupus Erythematosus (SLE)
|
|
Mechanism explaining SLE
|
Autoimmune response
|
|
How is drug induced SLE distinguished from idiopathic SLE?
|
Drug induced most prevalent in Caucasians; idiopathic most prevalent in African-Americans.
Drug induced less prevalent in females. Drug induced usually resolves in several weeks; idiopathic remission is rare. No kidney or CNS problems in drug induced. |
|
Drug induced rash marked by blisters and epidermal detachment resulting from epidermal necrosis? This reaction usually presents with fever (above 102.2°F), sore throat and visual impairment.
|
Stevens Johnson Syndrome (SJS)
|
|
Mechanism explaining Stevens Johnson Syndrome (SJS)?
|
Drug induced epidermal apoptosis
|
|
Common drug causes of Stevens Johnson Syndrome?
|
Sulfonamides, lamotrigine, aromatic anticonvulsants and -oxicam NSAIDs.
Also associated with Antiepileptic Hypersensitivity Syndrome (AHS). |
|
Stevens johnson syndrome with >30% detachement?
|
Toxic Epidermal Necrolysis (TEN)
|
|
Reason for recommendation of genetic testing prior to treatment with carbamazepine?
|
SJS, TEN, and AHS are strongly associated with HLA-B* 1502, found almost exclusively in people of Asian decent.
Risk= one to six per 1,000 new Asian users. HLA-B* 1502 positive patients are also at increased risk with other antiepileptic drugs. |
|
Most common of all drug induced skin reactions?
|
Morbilliform Reactions
|
|
Treatment for drug induced immunologic skin reactions when discontinuation does not lead to remittance?
|
Systemic glucocorticoids. Severe cases may require epinephrine
|
|
Drug induced pruritis can be treated with?
|
Oral antihistamines, emollients and soothing baths
|
|
Only cutaneous reaction where drugs are the sole cause?
|
Fixed drug eruptions
|
|
Treatment for warfarin necrosis of the skin?
|
Vitamin K and heparin
Protein-C for protein-C deficient patients |
|
Where do the lesions occur in fixed frug eruptions?
|
Lips, hand, genitalia, face and oral mucosa
|
|
How do you distinguish phototoxicity vs.
photoallergy in photosensitivity reactions? |
Phototoxicity- nonimmunologic reaction caused by drugs or chemicals.
Photoallergy- immunologic reaction to an excited-state photosensitizer. |
|
Treatment for photosensitivity eruptions?
|
Avoid exposure to ultraviolet light.
Use high-potency sunscreens that block UV-A light |
|
What are Wickham’s Striae
|
Permanent white lines around the papules caused by lichenoid drug eruptions.
|
|
Desoximetasone (Topicort)
|
High potency topical steroid
|
|
Topical steroid that appears on the high potency and very high potency list?
|
Diflorasone diacetate (ApexiCon)
|
|
Aromatic anticonvulsants most likely to cause Stevens Johnson Syndrome?
|
Phenytoin, phenobarbital and carbamazepine
|
|
Halobetasol propionate (Ultravate)?
|
Very high potency topical steroid
|
|
Difference between Stevens Johnson Syndrome and Antiepileptic Hypersensitivity Syndrome (AHS)?
|
The skin does not actually peel in Antiepileptic Hypersensitivity Syndrome (AHS)
|
|
Topical steroid that appears in the medium and high potency list?
|
Triamcinolone acetonide
|